OverviewChartNewsTraderScreen

Morgan Stanley Call 260 PGR 21.03.../  DE000MG100M2  /

Stuttgart
26/09/2024  11:27:10 Chg.+0.04 Bid12:28:35 Ask12:28:35 Underlying Strike price Expiration date Option type
1.83EUR +2.23% 1.86
Bid Size: 2,000		 1.92
Ask Size: 2,000		 Progressive Corporat... 260.00 USD 21/03/2025 Call
Newsfile Corp 19/09 Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Newsfile Corp 17/09 Innovation Driving Cancer's Solid Tumors Market
GlobeNewswire 02/09 Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to ...
GlobeNewswire 30/08 MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Paten...
GlobeNewswire 30/08 Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA App...
GlobeNewswire 29/08 The Alignment Studio Announces Launch of Women’s Health Physiotherapy Services in Melbourne
GlobeNewswire 28/08 AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodege...
GlobeNewswire 26/08 Avalyn Announces Upcoming Presentations on its Lead Program AP01, Inhaled Pirfenidone, for the Treat...
GlobeNewswire 22/08 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 21/08 CPAClub™ and Caseware™ Partner to Elevate Audit Quality for Progressive Accounting Firms
GlobeNewswire 19/08 Emergent BioSolutions Responds to Mpox Public Health Emergency as Cases Surge in Africa
GlobeNewswire 19/08 Tiziana Life Sciences Appoints New Chief Executive Officer
GlobeNewswire 19/08 Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire 19/08 CN Issues Lockout Notice to Teamsters
GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 14/08 Progressive Reports July 2024 Results
GlobeNewswire 14/08 Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene ...
GlobeNewswire 14/08 Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
GlobeNewswire 13/08 Eyenovia to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire 12/08 Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
TeleTrader 11/08 Bank of Russia says rates could reach 20%
GlobeNewswire 08/08 Opthea to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference, August 15,...
GlobeNewswire 08/08 Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th
GlobeNewswire 07/08 Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Sus...